Agilon Health (AGL)
(Real Time Quote from BATS)
$6.87 USD
+0.12 (1.78%)
Updated Jul 26, 2024 09:50 AM ET
4-Sell of 5 4
D Value D Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AGL 6.87 +0.12(1.78%)
Will AGL be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AGL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AGL
Agilon (AGL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
New Strong Sell Stocks for March 25th
AGL: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Sell Stocks for March 15th
New Strong Sell Stocks for February 28th
Agilon (AGL) Reports Q4 Earnings: What Key Metrics Have to Say
Other News for AGL
Buy Rating Affirmed for Agree Realty With Positive Outlook and Strong Financials
agilon health Sets Date to Report Second Quarter 2024 Financial Results
Strong Q2 Performance and Positive Outlook Justify Buy Rating for Agree Realty
AGL Energy Set for 2024 Full-Year Results Release
Leslie's Issues Preliminary Financial Results, Joins Beyond Meat, Domino's And Other Big Stocks Moving Lower In Thursday's Pre-Market Session